The deal marks an effort by Reckitt’s to increase their presence in emerging markets such as India, “The acquisition of Paras is another step forward in RB’s growth strategy in consumer healthcare,” said Bart Becht, chief executive of Reckitt Benckiser.
“It creates a material healthcare business in India, one of the most promising healthcare markets in the world with the addition of number of strong and leading brands.”
Paras Pharmaceuticals specialises in over-the-counter pain relief products such as Moov ointment.
Are you looking for a new position in the Pharmaceutical Industry? Click here to search our current pharmaceutical jobs online now.